Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…03/10/2026

Stock Moderna, Inc. MRNA

Moderna, Inc. — Investlytic score 2/5 on the five criteria.

-
-
40/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 03/10/2026.

  • ✅ Price trend passed
  • ⚠️ Mixed growth
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2018 → 2019: 28.09%

Price change 2019 → 2020: 434.10%

Price change 2020 → 2021: 143.11%

Price change 2021 → 2022: -29.28%

Price change 2022 → 2023: -44.63%

Price change 2023 → 2024: -58.19%

Price change 2024 → 2025: -29.08%

Price change 2025 → 2026: 540.69%

Price change 2026 (year to date): 512.25%

Financial growth

Revenue CAGR (8 years): 46.37%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 0.22

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -23.31

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 7.14% from the high over 6 months.

Insufficient correction (< 10.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Moderna, Inc.–0.22+37.8 %🔒
EssilorLuxottica S.A.33.60.37+14.2 %–
Sanofi8.80.28+2.5 %–
Pfizer Inc.9.80.78−0.5 %–
AstraZeneca PLC18.50.61+3.9 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
07

Similar stocks